Does Rallies show Form 4 insider transactions for BCYC?

Yes. Rallies tracks BCYC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is BCYC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BCYC. It does not provide personalized investment advice.

BCYC (Bicycle Therapeutics plc American Depositary Shares) Stock Analysis - Insider Trades

Bicycle Therapeutics plc American Depositary Shares (BCYC) is a publicly traded Healthcare sector company. As of May 21, 2026, BCYC trades at $4.47 with a market cap of $304.38M and a P/E ratio of -1.22. BCYC moved +1.72% today. Year to date, BCYC is -33.13%; over the trailing twelve months it is -48.06%. Its 52-week range spans $4.24 to $28.67. Analyst consensus is buy with an average price target of $13.57. Rallies surfaces BCYC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BCYC stock inside the company?

Recent BCYC insider activity includes Hannay Michael Charles Ferguson sold 251, Thompson Travis Alvin sold 102, Perry Jennifer Scott sold 37, Perry Jennifer Scott sold 333, and Lee Kevin sold 1.72K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BCYC Key Metrics

Key financial metrics for BCYC
Metric	Value
Price	$4.47
Market Cap	$304.38M
P/E Ratio	-1.22
EPS	$-3.62
Dividend Yield	0.00%
52-Week High	$28.67
52-Week Low	$4.24
Volume	7
Avg Volume	0
Revenue (TTM)	$28.34M
Net Income	$-250.66M
Gross Margin	0.00%

Recent BCYC Insider Trades

Hannay Michael Charles Ferguson sold 251 (~$1.27K) on Apr 6, 2026.
Thompson Travis Alvin sold 102 (~$515.1) on Apr 6, 2026.
Perry Jennifer Scott sold 37 (~$186.85) on Apr 6, 2026.
Perry Jennifer Scott sold 333 (~$1.68K) on Apr 6, 2026.
Lee Kevin sold 1.72K (~$8.67K) on Apr 6, 2026.

Latest BCYC News

Bicycle Therapeutics Depioritizes Zelenectide, Cuts Costs 50% and Extends Runway to 2030 — Mar 17, 2026

BCYC Analyst Consensus

8 analysts cover BCYC: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.57.

Common questions about BCYC

Who is trading BCYC stock inside the company?: Recent BCYC insider activity includes Hannay Michael Charles Ferguson sold 251, Thompson Travis Alvin sold 102, Perry Jennifer Scott sold 37, Perry Jennifer Scott sold 333, and Lee Kevin sold 1.72K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BCYC?: Yes. Rallies tracks BCYC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BCYC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BCYC. It does not provide personalized investment advice.